---
$id: https://graph.org.ai/products/commodity/51284009
$type: Product
source: UNSPSC
code: "51284009"
title: "Lymecycline"
class: "51284000"
classTitle: "Tetracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lymecycline

**UNSPSC Code**: 51284009
**Class**: [Tetracyclines](Tetracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tetracycline antibiotic with the molecular formula C29H38N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7D6EM3S13P, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but generally known as lymecycline, which bears US NIH Compound Identifier 5280963. European Medicines Agency schedules Lymecycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08625MIG. The term LYMECYCLINE is an International Non-Proprietary Name. World Health Organization schedules lymecycline in its Anatomical Therapeutic Chemical (ATC) Classification. LYMECYCLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lymecycline under HS 29413000 and SITC 54133. As of Q4 2014, LYMECYCLINE remains the US FDA Preferred Term for this commodity. Lymecycline bears US NLM identifiers UMLS ID C0024200 and NCI Concept Code C76991. SMILES: CLC1C2C(O)(C3CC4C(O)(C(=O)C3=C(O)C2C(O)CC1)C(=O)/C(=C(\O)N)C(=O)C4N(C)C)C.

